Recent

% | $
Quotes you view appear here for quick access.

SIGA Technologies Inc. Message Board

want2chouffe 21 posts  |  Last Activity: May 3, 2015 9:36 AM Member since: Jun 16, 2007
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    MCET Starts Phase 3 of their drug MCT-125

    by etcsjeffrey Feb 10, 2015 9:55 AM
    want2chouffe want2chouffe Feb 10, 2015 3:13 PM Flag

    The patent expires in 2019, there is not nearly enough time to develop the drug and run the Phase IIb and Phase III trials. Phase IIa was run by Amarin before the license. Nice deceptive subject line, clearly part of the scam. Yet another extremely optimistic press release by MCET.

    "MultiCell estimates MCT-125 could generate up to $3 billion in cumulative worldwide sales during the time MCT-125 is under patent protection"

    There will be no trials.

SIGA
2.050.0000(0.00%)Mar 19 4:00 PMEDT